UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Elexacaftor is a CFTR potentiator and acts synergistically with ivacaftor during acute and chronic treatment

Scientific reports, 2021-10, Vol.11 (1), p.19810-19810, Article 19810

2021

Volltextzugriff (PDF)

CFTR Is a Negative Regulator of NFκB Mediated Innate Immune Response

PloS one, 2009-02, Vol.4 (2), p.e4664

2009

Volltextzugriff (PDF)

Airway microbiota across age and disease spectrum in cystic fibrosis

The European respiratory journal, 2017-11, Vol.50 (5), p.1700832-1700832

2017

Volltextzugriff (PDF)

Receptor-mediated activation of CFTR via prostaglandin signaling pathways in the airway

American journal of physiology. Lung cellular and molecular physiology, 2022-03, Vol.322 (3), p.L305-L314

2022

Volltextzugriff (PDF)

Author Correction: Elexacaftor is a CFTR potentiator and acts synergistically with ivacaftor during acute and chronic treatment

Scientific reports, 2021-10, Vol.11 (1), p.21295-21295, Article 21295

2021

Volltextzugriff (PDF)

Clinical Phenotypes and Genotypic Spectrum of Cystic Fibrosis in Chinese Children

The Journal of pediatrics, 2016-04, Vol.171, p.269-276.e1

2016

Volltextzugriff (PDF)

Measurements of spontaneous CFTR-mediated ion transport without acute channel activation in airway epithelial cultures after modulator exposure

Scientific reports, 2021-11, Vol.11 (1), p.22616-22616, Article 22616

2021

Volltextzugriff (PDF)

The Changing Face of Cystic Fibrosis: An Update for Anesthesiologists

Anesthesia and analgesia, 2022-06, Vol.134 (6), p.1245-1259

2022

Volltextzugriff (PDF)

Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier

Proceedings of the National Academy of Sciences - PNAS, 2009-11, Vol.106 (46), p.19268-19273

2009

Volltextzugriff (PDF)

The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles

Biomaterials, 2009-05, Vol.30 (13), p.2591-2597

2009

Volltextzugriff (PDF)

Net benefit of ivacaftor during prolonged tezacaftor/elexacaftor exposure in vitro

Journal of cystic fibrosis, 2022-07, Vol.21 (4), p.637-643

2022

Volltextzugriff (PDF)

Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial

Human gene therapy, 2007-08, Vol.18 (8), p.726-732

2007

Volltextzugriff (PDF)

Impact of sleep opportunity on asthma outcomes in adolescents

Sleep medicine, 2020-01, Vol.65, p.134-141

2020

Volltextzugriff (PDF)

Cystic fibrosis and estrogens: a perfect storm

The Journal of clinical investigation, 2008-12, Vol.118 (12), p.3841-3844

Zeitlin, Pamela L

2008

Volltextzugriff (PDF)

Characterizing mucociliary clearance in young children with cystic fibrosis

Pediatric research, 2022-02, Vol.91 (3), p.612-620

2022

Volltextzugriff (PDF)

IL-13-programmed airway tuft cells produce PGE2, which promotes CFTR-dependent mucociliary function

JCI insight, 2022-07, Vol.7 (13)

2022

Volltextzugriff (PDF)

Pharmacokinetics and safety of cavosonstat (N91115) in healthy and cystic fibrosis adults homozygous for F508DEL-CFTR

Journal of cystic fibrosis, 2017-05, Vol.16 (3), p.371-379

2017

Volltextzugriff (PDF)

Expanding CFTR Modulator Testing to Carriers of CFTR Variants

Annals of the American Thoracic Society, 2021-11, Vol.18 (11), p.1776-1779

2021

Volltextzugriff (PDF)

Effect of apical chloride concentration on the measurement of responses to CFTR modulation in airway epithelia cultured from nasal brushings

Physiological reports, 2020-10, Vol.8 (19), p.e14603-n/a

2020

Volltextzugriff (PDF)

Changes in mucociliary clearance over time in children with cystic fibrosis

Pediatric pulmonology, 2020-09, Vol.55 (9), p.2307-2314

2020

Volltextzugriff (PDF)

N-acetylcysteine Enhances Cystic Fibrosis Sputum Penetration and Airway Gene Transfer by Highly Compacted DNA Nanoparticles

Molecular therapy, 2011-11, Vol.19 (11), p.1981-1989

2011

Volltextzugriff (PDF)

Dual activation of CFTR and CLCN2 by lubiprostone in murine nasal epithelia

American journal of physiology. Lung cellular and molecular physiology, 2013-03, Vol.304 (5), p.L324-L331

2013

Volltextzugriff (PDF)

Digitoxin for Airway Inflammation in Cystic Fibrosis: Preliminary Assessment of Safety, Pharmacokinetics, and Dose Finding

Annals of the American Thoracic Society, 2017-02, Vol.14 (2), p.220-229

2017

Volltextzugriff (PDF)

Effect of ivacaftor on mucociliary clearance and clinical outcomes in cystic fibrosis patients with G551D-CFTR

JCI insight, 2018-12, Vol.3 (24)

2018

Volltextzugriff (PDF)

1 – 25 von 214

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(199)
Mit Volltextzugriff
(193)

Publikationsform

Sprache

Englisch
(214)

Erscheinungsjahr

n.n

Thema

Science & Technology
(123)
Life Sciences & Biomedicine
(111)
Humans
(110)
Cystic Fibrosis
(82)
Biological And Medical Sciences
(57)
Respiratory System
(51)
Female
(47)
Medical Sciences
(43)
Male
(42)
Animals
(39)
Adult
(36)
Cystic Fibrosis - Genetics
(36)
Cystic Fibrosis Transmembrane Conductance Regulator - Genetics
(34)
Cystic Fibrosis - Metabolism
(33)
Mutation
(31)
Adolescent
(30)
Cystic Fibrosis - Drug Therapy
(27)
Child
(26)
Cystic Fibrosis Transmembrane Conductance Regulator - Metabolism
(24)
Pediatrics
(23)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Elexacaftor is a CFTR potentiator and acts synergistically with ivacaftor during acute and chronic treatment

CFTR Is a Negative Regulator of NFκB Mediated Innate Immune Response

Airway microbiota across age and disease spectrum in cystic fibrosis

Receptor-mediated activation of CFTR via prostaglandin signaling pathways in the airway

Author Correction: Elexacaftor is a CFTR potentiator and acts synergistically with ivacaftor during acute and chronic treatment

Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial

Clinical Phenotypes and Genotypic Spectrum of Cystic Fibrosis in Chinese Children

Measurements of spontaneous CFTR-mediated ion transport without acute channel activation in airway epithelial cultures after modulator exposure

The Changing Face of Cystic Fibrosis: An Update for Anesthesiologists

Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier

The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles

Net benefit of ivacaftor during prolonged tezacaftor/elexacaftor exposure in vitro

Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial

Impact of sleep opportunity on asthma outcomes in adolescents

Cystic fibrosis and estrogens: a perfect storm

Characterizing mucociliary clearance in young children with cystic fibrosis

IL-13-programmed airway tuft cells produce PGE2, which promotes CFTR-dependent mucociliary function

Pharmacokinetics and safety of cavosonstat (N91115) in healthy and cystic fibrosis adults homozygous for F508DEL-CFTR

Expanding CFTR Modulator Testing to Carriers of CFTR Variants

Effect of apical chloride concentration on the measurement of responses to CFTR modulation in airway epithelia cultured from nasal brushings

Changes in mucociliary clearance over time in children with cystic fibrosis

N-acetylcysteine Enhances Cystic Fibrosis Sputum Penetration and Airway Gene Transfer by Highly Compacted DNA Nanoparticles

Dual activation of CFTR and CLCN2 by lubiprostone in murine nasal epithelia

Digitoxin for Airway Inflammation in Cystic Fibrosis: Preliminary Assessment of Safety, Pharmacokinetics, and Dose Finding

Effect of ivacaftor on mucociliary clearance and clinical outcomes in cystic fibrosis patients with G551D-CFTR

Suchergebnisse filtern